| Year |
Citation |
Score |
| 2021 |
Muthengi A, Wimalasena VK, Yosief HO, Bikowitz MJ, Sigua LH, Wang T, Li D, Gaieb Z, Dhawan G, Liu S, Erickson J, Amaro RE, Schönbrunn E, Qi J, Zhang W. Development of Dimethylisoxazole-Attached Imidazo[1,2-]pyridines as Potent and Selective CBP/P300 Inhibitors. Journal of Medicinal Chemistry. PMID 33872011 DOI: 10.1021/acs.jmedchem.0c02232 |
0.329 |
|
| 2020 |
Zhou D, Hayashi T, Jean M, Kong W, Fiches G, Biswas A, Liu S, Yosief HO, Zhang X, Bradner J, Qi J, Zhang W, Santoso N, Zhu J. Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4 T cells ex vivo. Science Advances. 6: eaba1941. PMID 32832623 DOI: 10.1126/Sciadv.Aba1941 |
0.353 |
|
| 2019 |
Timme N, Han Y, Liu S, Yosief HO, García HD, Bei Y, Klironomos F, MacArthur IC, Szymansky A, von Stebut J, Bardinet V, Dohna C, Künkele A, Rolff J, Hundsdörfer P, et al. Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors. Translational Oncology. 13: 221-232. PMID 31869746 DOI: 10.1016/J.Tranon.2019.09.013 |
0.368 |
|
| 2019 |
Kong W, Hayashi T, Fiches G, Xu Q, Li M, Que J, Liu S, Zhang W, Qi J, Santoso N, Elledge SJ, Zhu J. Diversified Application of Barcoded PLATO (PLATO-BC) Platform for Identification of Protein Interactions. Genomics, Proteomics & Bioinformatics. PMID 31494268 DOI: 10.1016/J.Gpb.2018.12.010 |
0.314 |
|
| 2019 |
Gui B, Gui F, Takai T, Feng C, Bai X, Fazli L, Dong X, Liu S, Zhang X, Zhang W, Kibel AS, Jia L. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Proceedings of the National Academy of Sciences of the United States of America. PMID 31266892 DOI: 10.1073/Pnas.1908547116 |
0.442 |
|
| 2018 |
Liu S, Yosief HO, Dai L, Huang H, Dhawan G, Zhang X, Muthengi AM, Roberts J, Buckley DL, Perry JA, Wu L, Bradner JE, Qi J, Zhang W. Structure-guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) Inhibitors. Journal of Medicinal Chemistry. PMID 30125504 DOI: 10.1021/Acs.Jmedchem.8B00765 |
0.485 |
|
| 2018 |
Timme N, Liu S, Yosief H, García HD, MacArthur I, Szymansky A, Dohna C, Seifert G, Hundsdörfer P, Lissat A, Eggert A, Schulte J, Zhang W, Henssen A. Abstract 2624: Dual PLK1 and BRD4 inhibition has synergistic therapeutic effects against high-risk rhabdomyosarcoma Cancer Research. 78: 2624-2624. DOI: 10.1158/1538-7445.Am2018-2624 |
0.334 |
|
| 2017 |
Huang H, Liu S, Jean M, Simpson S, Huang H, Merkley M, Hayashi T, Kong W, Rodríguez-Sánchez I, Zhang X, Yosief HO, Miao H, Que J, Kobie JJ, Bradner J, et al. A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association. Frontiers in Microbiology. 8: 1035. PMID 28638377 DOI: 10.3389/Fmicb.2017.01035 |
0.505 |
|
| 2016 |
Koblan LW, Buckley DL, Ott CJ, Fitzgerald ME, Ember SW, Zhu JY, Liu S, Roberts JM, Remillard D, Vittori S, Zhang W, Schonbrunn E, Bradner JE. Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET. Chemmedchem. PMID 27862999 DOI: 10.1002/Cmdc.201600502 |
0.403 |
|
| 2016 |
Zhang X, Pham K, Liu S, Legris M, Muthengi A, Jasinski JP, Zhang W. Stereoselective synthesis of fused tetrahydroquinazolines through one-pot double [3 + 2] dipolar cycloadditions followed by [5 + 1] annulation. Beilstein Journal of Organic Chemistry. 12: 2204-2210. PMID 27829928 DOI: 10.3762/Bjoc.12.211 |
0.498 |
|
| 2016 |
Yang G, Buhrlage S, Tan L, Liu X, Chen J, Xu L, Tsakmaklis N, Chen JG, Patterson CJ, Brown JR, Castillo JJ, Zhang W, Zhang X, Liu S, Cohen P, et al. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood. PMID 27143257 DOI: 10.1182/Blood-2016-01-695098 |
0.498 |
|
| 2015 |
Urick AK, Hawk LM, Cassel MK, Mishra NK, Liu S, Adhikari N, Zhang W, Dos Santos CO, Hall JL, Pomerantz WC. Dual screening of BPTF and Brd4 using protein-observed fluorine NMR uncovers new bromodomain probe molecules. Acs Chemical Biology. PMID 26158404 DOI: 10.1021/Acschembio.5B00483 |
0.351 |
|
| 2014 |
McKeown MR, Shaw DL, Fu H, Liu S, Xu X, Marineau JJ, Huang Y, Zhang X, Buckley DL, Kadam A, Zhang Z, Blacklow SC, Qi J, Zhang W, Bradner JE. Biased multicomponent reactions to develop novel bromodomain inhibitors. Journal of Medicinal Chemistry. 57: 9019-27. PMID 25314271 DOI: 10.1021/Jm501120Z |
0.665 |
|
| 2014 |
Vetter ML, Zhang Z, Liu S, Wang J, Cho H, Zhang J, Zhang W, Gray NS, Yang PL. Fluorescent visualization of Src by using dasatinib-BODIPY. Chembiochem : a European Journal of Chemical Biology. 15: 1317-24. PMID 24828915 DOI: 10.1002/Cbic.201402010 |
0.605 |
|
| Show low-probability matches. |